• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation.

作者信息

Gill John S, Tonelli Marcello

机构信息

Division of Nephrology, University of British Columbia, Vancouver, Canada.

出版信息

N Engl J Med. 2012 Feb 16;366(7):586-9. doi: 10.1056/NEJMp1114394. Epub 2012 Feb 1.

DOI:10.1056/NEJMp1114394
PMID:22296029
Abstract
摘要

相似文献

1
Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation.小事聪明，大事糊涂？肾移植后免疫抑制的覆盖范围限制
N Engl J Med. 2012 Feb 16;366(7):586-9. doi: 10.1056/NEJMp1114394. Epub 2012 Feb 1.
2
Drug coverage for transplantation turns into political football: big business trumps patients.移植药物保险成为政治足球：大企业胜过患者。
Clin J Am Soc Nephrol. 2010 May;5(5):746-7. doi: 10.2215/CJN.01630210. Epub 2010 May 6.
3
Cost-effectiveness of Medicare's coverage of immunosuppression medications for kidney transplant recipients.医疗保险对肾移植受者免疫抑制药物覆盖的成本效益。
Expert Rev Pharmacoecon Outcomes Res. 2009 Oct;9(5):435-44. doi: 10.1586/erp.09.52.
4
An (ongoing) shortsighted view on transplant coverage policy.对移植覆盖政策的一种（持续的）短视观点。
Nephrol News Issues. 2012 Mar;26(3):8, 10.
5
Extension of Medicare immunosuppressive drug benefits: a "no brainer" that did not happen.医疗保险免疫抑制药物福利的扩展：一件“显而易见的事”却未实现。
Clin J Am Soc Nephrol. 2010 May;5(5):743. doi: 10.2215/CJN.01680210. Epub 2010 May 6.
6
Insurance woes threaten gift of life.
Nephrol News Issues. 2008 Aug;22(9):48-9.
7
Until we get lifetime coverage for immunosuppressive medications, the underground will thrive.
Nephrol News Issues. 1999 Aug;13(8):18.
8
Health insurance considerations for adolescent transplant recipients as they transition to adulthood.青少年移植受者向成年期过渡时的健康保险考量
Pediatr Transplant. 2007 Mar;11(2):127-31. doi: 10.1111/j.1399-3046.2006.00639.x.
9
Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.在当前时代，扩大医疗保险免疫抑制药物覆盖范围以惠及肾移植受者的经济评估。
J Am Soc Nephrol. 2020 Jan;31(1):218-228. doi: 10.1681/ASN.2019070646. Epub 2019 Nov 8.
10
What does it mean for patients? The expanded Medicare coverage of immunosuppressive medications.这对患者意味着什么？医疗保险对免疫抑制药物覆盖范围的扩大。
Nephrol News Issues. 2001 May;Suppl:S15-7.

引用本文的文献

1
Impact of public versus non public insurance on hispanic kidney transplant outcomes using UNOS database.利用器官共享联合网络（UNOS）数据库研究公共保险与非公共保险对西班牙裔肾移植结果的影响。
Sci Rep. 2025 Feb 10;15(1):4879. doi: 10.1038/s41598-025-88672-3.
2
Individual- and Community-Level Socioeconomic Status and Deceased Donor Renal Transplant Outcomes.个体及社区层面的社会经济地位与 deceased 捐赠者肾移植结果
J Racial Ethn Health Disparities. 2025 Feb;12(1):68-78. doi: 10.1007/s40615-023-01851-8. Epub 2023 Nov 14.
3
Organization of Post-Transplant Care and the 5-Year Outcomes of Kidney Transplantation.
移植后护理的组织和肾移植的 5 年结果。
Int J Environ Res Public Health. 2022 Feb 11;19(4):2010. doi: 10.3390/ijerph19042010.
4
After 20 Years of Advocacy, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Finally Become Law.经过20年的倡导，肾脏移植患者的全面免疫抑制药物覆盖范围终于成为法律。
Transplantation. 2022 Jan 1;106(1):9-11. doi: 10.1097/TP.0000000000003899.
5
Validation of a survival benefit estimator tool in a cohort of European kidney transplant recipients.验证一种生存获益估算工具在欧洲肾移植受者队列中的适用性。
Sci Rep. 2020 Oct 13;10(1):17109. doi: 10.1038/s41598-020-74295-3.
6
The correlation of patients' anxiety after a liver or kidney transplantation with functional and self-reported work ability.肝或肾移植术后患者焦虑情绪与功能及自我报告工作能力的相关性
Medicine (Baltimore). 2020 May;99(18):e20108. doi: 10.1097/MD.0000000000020108.
7
Use of the Living Kidney Donor Profile Index in the Canadian Kidney Transplant Recipient Population: A Validation Study.活体肾供体配型指数在加拿大肾移植受者群体中的应用：一项验证研究。
Can J Kidney Health Dis. 2020 Feb 20;7:2054358120906976. doi: 10.1177/2054358120906976. eCollection 2020.
8
HOUSES Index as an Innovative Socioeconomic Measure Predicts Graft Failure Among Kidney Transplant Recipients.HOUSES 指数作为一种创新性的社会经济衡量指标，可预测肾移植受者的移植物失功。
Transplantation. 2020 Nov;104(11):2383-2392. doi: 10.1097/TP.0000000000003131.
9
Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.在当前时代，扩大医疗保险免疫抑制药物覆盖范围以惠及肾移植受者的经济评估。
J Am Soc Nephrol. 2020 Jan;31(1):218-228. doi: 10.1681/ASN.2019070646. Epub 2019 Nov 8.
10
Multivariate analysis of biopsychosocial determinants of professional activity among patients after kidney or liver transplantation in Poland.波兰肾或肝移植患者职业活动的生物心理社会决定因素的多变量分析。
BMJ Open. 2019 Jul 9;9(7):e029501. doi: 10.1136/bmjopen-2019-029501.